The Sputnik V vaccine was developed by Gamaleya NRCEM. Similarly to the Oxford-AstraZeneca vaccine, it is based on a viral vector, and its findings were published in Lancet. The Russian vaccine comprises two different adenoviruses in the first and the second dose, making it more effective and generating an extended immune response. Both vectors carry…